DarioHealth Corp. intends to offer and sell its common shares in an underwritten public offering.

Net proceeds will be used for the commercialization efforts of company's products, including increased marketing and production expenses, and for general working capital purposes.

Aegis Capital Corp. is acting as the sole book-running manager for the offering.